Advertisement

The effect of deslanoside on the duration of the phases of ventricular systole in man

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      In the present investigation we studied the effect of deslanoside on the duration of the phases of left ventricular systole as derived indirectly from simultaneous tracings of the electrocardiogram, the heart sounds and the external carotid arterial tracing. The phases of systole measured included the interval between the beginning of electrical activity and the second heart sound (Q-S2), the interval between the first and second heart sound S1-S2 and the interval between beginning ejection and the trough of the incisura of the carotid pulse tracing (LVET). All data were expressed relative to the regression relationships between heart rate and each of the measured intervals.
      Deslanoside, administered intravenously (1.6 mg.), induced a decrease in the duration of each of the measured phases of left ventricular systole. The abbreviation in Q-S2 and S1-S2 exceeded that in LVET, lending evidence for a decrease in both the pre-ejection and ejection phases of the cardiac cycle. Studies on the temporal course of this action of deslanoside demonstrated the presence of an effect at 10 minutes, with progression to a maximum at one to two hours, after which the abbreviation in systole remained relatively constant for eight hours. Studies over the ensuing five days revealed a serial dissipation of the drug effect. The mean response in the duration of each of the phases of systole during the first eight hours following administration of deslanoside proved to be dose-dependent.
      A significant diurnal abbreviation in the duration of the phases of left ventricular systole was observed. This diurnal effect must be considered in all studies involving serial measurements of the duration of the phases of the cardiac cycle.
      The determination of the duration of the phases of left ventricular systole offers a useful means for assaying digitalis effects on the human ventricle.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weissler A.M.
        • Gamel W.G.
        • Grode H.E.
        • Cohen S.
        • Schoenfeld C.D.
        The effect of digitalis on ventricular ejection in normal human subjects.
        Circulation. 1964; 29: 721
        • Wiggers C.J.
        • Stimson B.
        Studies on cardiodynamic actions of drugs. III. Mechanism of cardiac stimulation by digitalis and g-strophanthin.
        J. Pharm. & Exper. Therap. 1927; 30: 251
        • Cotten M.deV.
        • Bay E.
        Direct measurement of changes in cardiac contractile force; relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function.
        Am. J. Physiol. 1956; 187: 122
        • Wallace A.G.
        • Mitchell J.H.
        • Skinner N.S.
        • Sarnoff S.J.
        Duration of the phases of left ventricular systole.
        Circulation Res. 1963; 12: 611
        • Lehmann C.H.
        Analytical Geometry.
        in: Wiley and Sons Inc, London1942: 92
        • Snedecor G.W.
        Statistical Methods.
        in: ed. 5. The Iowa State College Press, Ames, Iowa1956
        • Blumberger K.
        Die Untersuchung Dynamik des Herzens bein Menschen.
        Ergebn. inn. Med. u. Kinderh. 1942; 62: 434
        • Raab W.
        • DePaula e Silva P.
        • Starcheska Y.K.
        Adrenergic and cholinergic influences on the dynamic cycle of the normal human heart.
        Cardiologia. 1958; 33: 350
        • Luisada A.A.
        • Liu C.K.
        • Aravanis C.
        • Testelli M.
        • Morris J.
        On the mechanism of production of the heart sounds.
        Am. Heart J. 1958; 55: 383
        • Weissler A.M.
        • Peeler R.G.
        • Roehll Jr., W.H.
        Relationships between left ventricular ejection time, stroke volume, and heart rate in normal individuals and patients with cardiovascular disease.
        Am. Heart J. 1961; 62: 367
        • Benchimol A.
        • Dimond E.G.
        • Shen Y.
        Ejection time in aortic stenosis and mitral stenosis.
        Am. J. Cardiol. 1960; 5: 728
        • Lombard W.P.
        • Cope O.M.
        Duration of the systole of the left ventricle of man.
        Am. J. Physiol. 1926; 77: 263
        • Kuhns K.
        Untersuchungen uber die mechanische und elektrische Systolendauer. Ein Beitrag zum Problem der “energetisch-dynamischen Herzinsuffizienz” (Hegglin).
        Cardiologia. 1953; 23: 305
        • Gobbato F.
        • Meda A.
        Analysis of factors that may influence the duration of isotonic systole in normal conditions.
        Cardiologia. 1956; 29: 144
        • Harris L.C.
        • et al.
        The duration of the phases of mechanical systole in infants and children.
        Am. J. Cardiol. 1964; 14: 448
        • Sambhi M.P.
        The isometric period of contraction as a determinant of cardiac performance and digitalis action.
        Am. J. Cardiol. 1960; 6: 1042
        • Walton R.P.
        • Leary J.S.
        • Jones H.P.
        Comparative increase in ventricular contractile force produced by several cardiac glycosides.
        J. Pharm. & Exper. Therap. 1950; 98: 346
        • Gold H.
        • Cattell McK.
        • Otto H.L.
        • Kwit N.T.
        • Kramer M.L.
        A method for the bioassay of digitalis in humans.
        J. Pharm. & Exper. Therap. 1942; 75: 196
        • Gold H.
        • Kwit N.T.
        • Cattell McK.
        Studies on purified digitalis glucosides. I. Potency and dosage of “digitaline nativelle” by oral administration in man.
        J. Pharm. & Exper. Therap. 1940; 69: 177
        • Gold H.
        Pharmacologic basis of cardiac therapy.
        J.A.M.A. 1946; 132: 547
        • Dieuaide F.R.
        • Tung C.L.
        • Bien C.W.A
        study of the standardization of digitalis. I. A method for clinical standardization.
        J. Clin. Invest. 1935; 14: 725
        • Berliner K.
        Observations on the duration of the electrical systole of the heart, with special reference to the effect of digitalis.
        Am. Heart J. 1931–1932; 7: 189
        • Gilchrist A.R.
        • Lyon D.M.
        The clinical comparison of three preparations of digitalis.
        J. Pharm.& Exper. Therap. 1927; 31: 319
        • Martin L.F.
        A clinical standardization of digitalis.
        J. Pharm. & Exper. Therap. 1927; 31: 229
        • Simson G.
        Digitalis assay.
        Am. Heart J. 1962; 64: 401